The restriction of glucose supplies due to the high rates of glycolysis in tumor cells impairs the anti-tumor function of CD4+ T cells, possibly by blocking the secretion of IFN-γ (Chang et al., 2015; Ho et al., 2015). Here, IFNG is linked to neoplasm.